Alnylam Pharmaceuticals | ALNY - Zobowiązania





Zobowiązania Zmiana Data
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amgen USD 23.23B 2.27B 2026-09
Arrowhead Research USD 283.35M 11.87M 2026-06
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Moderna USD 2.53B 139M 2026-06
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novartis USD 32.52B 1.15B 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 31.93B 1.92B 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Takeda JPY 2.6T 161B 2026-09
Tectonic Therapeutic USD 10.37M 2.59M 2026-06
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09
Xencor USD 76.27M 5.6M 2026-09